These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 14531460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Solubility enhancement of celecoxib using beta-cyclodextrin inclusion complexes.
    Rawat S, Jain SK.
    Eur J Pharm Biopharm; 2004 Mar; 57(2):263-7. PubMed ID: 15018983
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
    Badr-Eldin SM, Elkheshen SA, Ghorab MM.
    Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
    [Abstract] [Full Text] [Related]

  • 6. Nimesulide and beta-cyclodextrin inclusion complexes: physicochemical characterization and dissolution rate studies.
    Chowdary KP, Nalluri BN.
    Drug Dev Ind Pharm; 2000 Nov; 26(11):1217-20. PubMed ID: 11068697
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
    Onyeji CO, Omoruyi SI, Oladimeji FA.
    Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Inclusion complex of 3,9-bis(N,N-dimethylcarbamoyloxy)-5H-benzofuro[3,2-c]quinoline-6-one (KCA-098) with heptakis(2,6-di-O-methyl)-beta-cyclodextrin: interaction and dissolution properties.
    Yamada T, Imai T, Ouchi K, Otagiri M, Hirayama F, Uekama K.
    Chem Pharm Bull (Tokyo); 2000 Sep; 48(9):1264-9. PubMed ID: 10993223
    [Abstract] [Full Text] [Related]

  • 15. Preparation and characterization of inclusion complex of norflurazon and beta-cyclodextrin to improve herbicide formulations.
    Villaverde J, Morillo E, Pérez-Martínez JI, Ginés JM, Maqueda C.
    J Agric Food Chem; 2004 Feb 25; 52(4):864-9. PubMed ID: 14969543
    [Abstract] [Full Text] [Related]

  • 16. Dissolution properties of praziquantel-beta-cyclodextrin systems.
    el-Arini SK, Leuenberger H.
    Pharm Dev Technol; 1996 Oct 25; 1(3):307-15. PubMed ID: 9552314
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Improvement of dissolution properties of furosemide by complexation with beta-cyclodextrin.
    Ozdemir N, Ordu S.
    Drug Dev Ind Pharm; 1998 Jan 25; 24(1):19-25. PubMed ID: 15605593
    [Abstract] [Full Text] [Related]

  • 19. Solid-state characterization and dissolution properties of bicalutamide-beta-cyclodextrin inclusion complex.
    Patil AL, Pore YV, Kuchekar BS, Late SG.
    Pharmazie; 2008 Apr 25; 63(4):282-5. PubMed ID: 18468387
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.